Literature DB >> 9435422

Hepatitis C-associated osteosclerosis: late onset after blood transfusion in an elderly woman.

J L Shaker1, W R Reinus, M P Whyte.   

Abstract

A 69-yr-old woman with hepatitis C virus (HCV) infection from blood transfusion 14 yr earlier was evaluated in 1997 for increasing appendicular skeletal pain. Diffusely elevated radioisotope uptake on bone scanning had appeared during the past 15 months. Radiographs spanning 1978-1997 showed remarkable restoration of bone mass and a skeleton like that of a young woman. Bone mineral densities of the femoral neck and lumbar spine were above the mean peak bone mass of young women (T scores, +1.8 and +1.3, respectively) and 160% and 147% of mean values for age-matched female controls (Z-score, +3.7 and +3.6, respectively). Biochemical markers of skeletal remodeling were substantially increased. Bone marrow biopsy showed normal lamellar bone. Serum alkaline phosphatase activity assays suggested that accelerated skeletal turnover began 6-12 months before symptoms. HC-associated osteosclerosis has been reported in nine individuals 27-73 yr of age, most with a history of i.v. drug abuse. Our patient demonstrates that parenteral exposure to blood rather than illicit drugs is the feature common to all affected subjects. Furthermore, we document that there can be a long latency between HCV infection and the development of skeletal abnormalities. We also find that bone mass can be restored by this disorder in a postmenopausal woman. Routine radiographs, however, may not show overt osteosclerosis in the elderly. The precise pathogenesis of this disorder is unknown. Understanding and control of the mechanism of HC-associated osteosclerosis could potentially lead to correction of low bone mass from osteoporosis with good quality skeletal tissue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9435422     DOI: 10.1210/jcem.83.1.4521

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  A case of hepatitis C-associated osteosclerosis that was improved with the combination therapy of peginterferon alfa-2b and ribavirin.

Authors:  Satoshi Shakado; Yuko Akehi; Kaoru Yotsumoto; Atsushi Fukunaga; Shizuka Kuno; Takashi Tanaka; Kunitoshi Sakurai; Hideyuki Iwashita; Shuichi Ueda; Genryu Hirano; Keiji Yokoyama; Daisuke Morihara; Shinya Nishizawa; Masaharu Sakamoto; Akira Anan; Yasuaki Takeyama; Makoto Irie; Kaoru Iwata; Tetsuro Sohda; Shotaro Sakisaka
Journal:  Clin J Gastroenterol       Date:  2011-06-10

2.  Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults.

Authors:  S Khosla; A A Hassoun; B K Baker; F Liu; N N Zein; M P Whyte; C A Reasner; T B Nippoldt; R D Tiegs; R L Hintz; C A Conover
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

3.  An uncommon cause of acquired osteosclerosis in adults: hepatitis C-associated osteosclerosis.

Authors:  Narendranath Epperla; Fergus E McKiernan
Journal:  Skeletal Radiol       Date:  2014-04-10       Impact factor: 2.199

4.  OPG/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key?

Authors:  Paolo Manganelli; Nicola Giuliani; Pieranna Fietta; Cristina Mancini; Mirca Lazzaretti; Angela Pollini; Federico Quaini; Mario Pedrazzoni
Journal:  Clin Rheumatol       Date:  2004-12-04       Impact factor: 2.980

5.  Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system.

Authors:  C E Fiore; S Riccobene; R Mangiafico; F Santoro; P Pennisi
Journal:  Osteoporos Int       Date:  2005-06-28       Impact factor: 4.507

6.  Hepatitis C-associated osteosclerosis: a case report.

Authors:  Kara M Schwartz; John A Skinner
Journal:  Skeletal Radiol       Date:  2008-04-15       Impact factor: 2.199

Review 7.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

8.  A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections.

Authors:  Edward K Chow; Antonio Castrillo; Arash Shahangian; Liming Pei; Ryan M O'Connell; Robert L Modlin; Peter Tontonoz; Genhong Cheng
Journal:  J Exp Med       Date:  2006-10-30       Impact factor: 14.307

9.  Serum sclerostin in hepatitis C virus infected patients.

Authors:  Emilio González-Reimers; Javier López-Prieto; Ricardo Pelazas-González; M Remedios Alemán-Valls; María José de la Vega-Prieto; Carlos Jorge-Ripper; M Carmen Durán-Castellón; F Santolaria-Fernández
Journal:  J Bone Metab       Date:  2014-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.